Net cost per number of cancers prevented for different strategies for screening and treatment of <i>H. pylori</i> in a population with a 75% prevalence of <i>H. pylori infection</i> shown as an Incremental Cost Effectiveness Ratio (ICER).

Abstract

<p>Red line indicates lowest net cost per cancer prevented.</p